Literature DB >> 9474807

Further investigation of the light chain shifting phenomenon: light chain replacement through secondary rearrangement induced by lectin stimulation in the hybridoma cell line HB4C5.

C Krungkasem1, K Ueda, H Tachibana, S Shirahata.   

Abstract

We found that when the hybridoma cell line HB4C5 was stimulated with wheat germ agglutinin (WGA), loss of production of the original lambda light chain occurred, followed by production of new light chain, which mirrored the reaction when stimulated with concanavalin A (ConA). We previously reported that the RAG genes are expressed not only in HB4C5 and its ConA-treated variant subclones, but also in the in the parental Namalwa cells, which are known to be in the plasma state. However, the new lambda light chains were expressed only in the HB4C5 cells and not in the parental Namalwa cells. Here we found that the RAG genes are expressed in HB4C5 cells after continuous stimulation with WGA. To further investigate the mechanism of this loss of original lambda light chain production by stimulation with lectins in HB4C5 cells, which leads to a sIg-negative subpopulation, we analyzed the differences between HB4C5 and Namalwa cells. In this present study, we found that a 70 kDa phosphorylated protein in HB4C5 cells became undetectable after stimulation with lectins (WGA and ConA), and was not detected in Namalwa cells before or after lectin stimulation. It has been believed that the RAG genes and loss of original lambda light chain production are required to induce expression of a new lambda light chain in the HB4C5 cells. We suggested that the phosphorylated 70 kDa protein in HB4C5 cells play important roles in regulating the production of new lambda light chains which is induced by lectins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9474807      PMCID: PMC3466735          DOI: 10.1023/a:1007943228587

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  30 in total

Review 1.  Transmembrane signals and intracellular "second messengers" in the regulation of quiescent B-lymphocyte activation.

Authors:  J C Cambier; L B Justement; M K Newell; Z Z Chen; L K Harris; V M Sandoval; M J Klemsz; J T Ransom
Journal:  Immunol Rev       Date:  1987-02       Impact factor: 12.988

Review 2.  Transgenic mice with immunoglobulin genes.

Authors:  U Storb
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

Review 3.  Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins.

Authors:  T Osawa; T Tsuji
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Initiation of V(D)J recombination in a cell-free system.

Authors:  D C van Gent; J F McBlane; D A Ramsden; M J Sadofsky; J E Hesse; M Gellert
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

5.  Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus.

Authors:  S Lewis; N Rosenberg; F Alt; D Baltimore
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

6.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes.

Authors:  Z Z Chen; K M Coggeshall; J C Cambier
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

9.  Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu.

Authors:  M C Nussenzweig; A C Shaw; E Sinn; D B Danner; K L Holmes; H C Morse; P Leder
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

10.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.